These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 18416958)

  • 1. Diagnostic accuracy of immunochemical faecal occult blood tests according to number of samples and positivity threshold.
    Guittet L; Launoy G
    J Med Screen; 2008; 15(1):48-9. PubMed ID: 18416958
    [No Abstract]   [Full Text] [Related]  

  • 2. Identification of colorectal adenomas by a quantitative immunochemical faecal occult blood screening test depends on adenoma characteristics, development threshold used and number of tests performed.
    Rozen P; Levi Z; Hazazi R; Waked A; Vilkin A; Maoz E; Birkenfeld S; Leshno M; Niv Y
    Aliment Pharmacol Ther; 2009 Apr; 29(8):906-17. PubMed ID: 19183147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Improvement in screening for colorectal cancer associated with the use of immunochemical faecal occult blood test].
    Launoy G
    Pathol Biol (Paris); 2009 Sep; 57(6):488-92. PubMed ID: 18834677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative evaluation of a new bedside faecal occult blood test in a prospective multicentre study.
    Hoepffner N; Shastri YM; Hanisch E; Rösch W; Mössner J; Caspary WF; Stein J
    Aliment Pharmacol Ther; 2006 Jan; 23(1):145-54. PubMed ID: 16393292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A quantitative immunochemical faecal occult blood test is more efficient for detecting significant colorectal neoplasia than a sensitive guaiac test.
    Levi Z; Hazazi R; Rozen P; Vilkin A; Waked A; Niv Y
    Aliment Pharmacol Ther; 2006 May; 23(9):1359-64. PubMed ID: 16629942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The immunochemical faecal occult blood test leads to higher compliance than the guaiac for colorectal cancer screening programmes: a cluster randomized controlled trial.
    Federici A; Giorgi Rossi P; Borgia P; Bartolozzi F; Farchi S; Gausticchi G
    J Med Screen; 2005; 12(2):83-8. PubMed ID: 15949119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colorectal cancer screening using immunochemical faecal occult blood testing in Japan.
    Saito H
    J Med Screen; 2006; 13 Suppl 1():S6-7. PubMed ID: 17227634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative study of immunochemical fecal tests for detection of colorectal adenomatous polyps.
    Nakama H; Fattah A; Zhang B; Uehara Y; Wang C
    Hepatogastroenterology; 2000; 47(32):386-9. PubMed ID: 10791196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Which colorectal cancer screening test is best?
    Mandel JS
    J Natl Cancer Inst; 2007 Oct; 99(19):1424-5. PubMed ID: 17895471
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunochemical fecal occult blood tests for colorectal cancer screening.
    Allison JE
    Am J Med; 2004 Apr; 116(7):498; author reply 498-9. PubMed ID: 15047043
    [No Abstract]   [Full Text] [Related]  

  • 11. Indirect comparison of two quantitative immunochemical faecal occult blood tests in a population with average colorectal cancer risk.
    Guittet L; Bailly L; Bouvier V; Launoy G
    J Med Screen; 2011; 18(2):76-81. PubMed ID: 21852699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for colorectal cancer.
    Guittet L; Launoy G
    N Engl J Med; 2010 Jan; 362(1):84-5; author reply 85. PubMed ID: 20054054
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunochemical versus guaiac fecal occult blood tests.
    Technol Eval Cent Assess Program Exec Summ; 2004 Jul; 19(5):1-3. PubMed ID: 15473055
    [No Abstract]   [Full Text] [Related]  

  • 14. Green-coloured results on guaiac-based faecal occult blood testing should be considered positive.
    Skitek M
    Ann Clin Biochem; 2005 May; 42(Pt 3):234-5; author reply 235. PubMed ID: 15949162
    [No Abstract]   [Full Text] [Related]  

  • 15. [Small benefit of many feces-Hb tests. Low diagnostic value of the immunochemical method according to a primary health care study].
    Högberg C; Asplund R
    Lakartidningen; 2010 May 26-Jun 1; 107(21):1372-5. PubMed ID: 20645610
    [No Abstract]   [Full Text] [Related]  

  • 16. [Faecal occult blood test and mass screening for colorectal cancer].
    Hiwatashi N; Shimada T
    Nihon Rinsho; 2003 Sep; 61 Suppl 7():201-6. PubMed ID: 14574882
    [No Abstract]   [Full Text] [Related]  

  • 17. [Colorectal cancer screening: immunological test for faecal occult blood preferred].
    Jansen JB; van Rossum LG; Laheij RJ
    Ned Tijdschr Geneeskd; 2009; 153():A474. PubMed ID: 19785842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic accuracy of faecal occult blood tests used in screening for colorectal cancer: a systematic review.
    Burch JA; Soares-Weiser K; St John DJ; Duffy S; Smith S; Kleijnen J; Westwood M
    J Med Screen; 2007; 14(3):132-7. PubMed ID: 17925085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitivity and specificity of several immunochemical tests for colorectal cancer.
    Nakama H; Kamijo N; Miyata K; Abdul Fattah AS; Zhang B; Uehara Y
    Hepatogastroenterology; 1998; 45(23):1579-82. PubMed ID: 9840108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of fecal occult-blood screening on the incidence of colorectal cancer.
    Allison JE
    N Engl J Med; 2001 Mar; 344(13):1022; author reply 1023. PubMed ID: 11280326
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.